SHE:300497 Revenue

Jiangxi Fushine Pharmaceutical had revenue of 254.68M CNY in the quarter ending September 30, 2025, a decrease of -13.51%. This brings the company's revenue in the last twelve months to 970.32M, down -25.37% year-over-year. In the year 2024, Jiangxi Fushine Pharmaceutical had annual revenue of 1.18B, down -26.83%.

Revenue (ttm)

970.32M

Revenue Growth

-25.37%

P/S Ratio

9.36

Revenue / Employee

546.97K

Employees

1,774

Market Cap

9.08B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.18B	-431.82M	-26.83%
Dec 31, 2023	1.61B	-37.59M	-2.28%
Jan 1, 2023	1.65B	217.72M	15.23%
Jan 1, 2022	1.43B	-63.41M	-4.25%
Dec 31, 2020	1.49B	138.91M	10.26%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
WuXi AppTec	43.88B
Huadong Medicine	43.09B
Yunnan Baiyao Group Co.,Ltd	40.77B
Shanghai Fosun Pharmaceutical (Group)	39.55B
Shenzhen Mindray Bio-Medical Electronics	33.07B
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	30.98B
Zhejiang NHU Company	22.47B
Aier Eye Hospital Group	22.17B

Revenue Rankings